Bank of New York Mellon
THRD

Bank of New York Mellon’s Third Harmonic Bio THRD Stock Holding History

Bank of New York Mellon’s Portfolio THRD Stock Details THRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-53,358
Closed -$290K – 4262
2025
Q2 		$290K Buy
53,358
+7,437
+16% +$37.1K ﹤0.01% 3820
2025
Q1 		$159K Hold
45,921
– – ﹤0.01% 3935
2024
Q4 		$473K Sell
45,921
-342
-0.7% -$4.26K ﹤0.01% 3556
2024
Q3 		$627K Sell
46,263
-15,336
-25% -$190K ﹤0.01% 3385
2024
Q2 		$801K Buy
61,599
+7,373
+14% +$91.2K ﹤0.01% 3320
2024
Q1 		$512K Sell
54,226
-3,144
-5% -$30.6K ﹤0.01% 3512
2023
Q4 		$629K Sell
57,370
-180
-0.3% -$1.43K ﹤0.01% 3421
2023
Q3 		$368K Buy
57,550
+4,197
+8% +$25.6K ﹤0.01% 3710
2023
Q2 		$257K Buy
53,353
+16,916
+46% +$80.5K ﹤0.01% 3898
2023
Q1 		$150K Sell
36,437
-657
-2% -$2.79K ﹤0.01% 4002
2022
Q4 		$160K Buy
+37,094
New +$621K ﹤0.01% 4033

Other funds holding THRD

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 28.97% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
AB
Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
Optiver Holding
Optiver Holding Amsterdam, Netherlands $371B AUM 64.6% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Bank of New York Mellon's THRD Position: Q3 2025 in Review

Bank of New York Mellon sold out of Third Harmonic Bio (THRD) in Q3 2025, closing a stake of 53,358 shares — an estimated $290K sold.

Bank of New York Mellon first reported a position in THRD in Q4 2022 and held it in 11 quarters. The position peaked at $801K in Q2 2024. 18 funds tracked by Wall St. Rank hold THRD as of Q3 2025.

  • Bank of New York Mellon reported no remaining Third Harmonic Bio position as of Q3 2025 after selling out during the quarter.
  • Bank of New York Mellon sold 53,358 Third Harmonic Bio shares in Q3 2025, an estimated $290K.
  • Bank of New York Mellon first reported a position in Third Harmonic Bio in Q4 2022 and held it in 11 quarters.
  • Bank of New York Mellon's Third Harmonic Bio position peaked at $801K in Q2 2024.
  • 18 funds tracked by Wall St. Rank held Third Harmonic Bio as of Q3 2025.

Based on Bank of New York Mellon's 13F filing for Q3 2025, filed 3 Nov 2025.